Tobacco-related deaths remain the leading cause of preventable death in the United States. Veterans suffering from posttraumatic stress disorder (PTSD)—about 11% of those receiving care from the Department of Veterans Affairs (VA)—have triple the risk of developing tobacco use disorder (TUD). The most efficacious strategies being used at the VA for smoking cessation only result in a 23% abstinence rate, and veterans with PTSD only achieve a 4.5% abstinence rate. Therefore, there is a critical need to develop more effective treatments for smoking cessation. Recent studies suggest the insula is integrally involved in the neurocircuitry of TUD. Thus, we propose a feasibility phase II randomized controlled trial (RCT) to study a form of repetitive transcranial magnetic stimulation (rTMS) called intermittent theta burst stimulation (iTBS). iTBS has the advantage of allowing for a patterned form of stimulation delivery that we will administer at 90% of the subject’s resting motor threshold (rMT) applied over a region in the right post-central gyrus most functionally connected to the right posterior insula. We hypothesize that by increasing functional connectivity between the right post-central gyrus and the right posterior insula, withdrawal symptoms and short-term smoking cessation outcomes will improve. Fifty eligible veterans with comorbid TUD and PTSD will be randomly assigned to active-iTBS + cognitive behavioral therapy (CBT) + nicotine replacement therapy (NRT) (n = 25) or sham-iTBS + CBT + NRT (n = 25). The primary outcome, feasibility, will be determined by achieving a recruitment of 50 participants and retention rate of 80%. The success of iTBS will be evaluated through self-reported nicotine use, cravings, withdrawal symptoms, and abstinence following quit date (confirmed by bioverification) along with evaluation for target engagement through neuroimaging changes, specifically connectivity differences between the insula and other regions of interest.
Tobacco-related deaths exceed those resulting from homicides, suicides, motor vehicle accidence, alcohol consumption, illicit substance use, and acquired immunodeficiency syndrome (AIDS), combined. Amongst U.S. veterans, this trend is particularly concerning given that those suffering from posttraumatic stress disorder (PTSD)—about 11% of those receiving care from the Department of Veterans Affairs (VA)—have triple the risk of developing tobacco use disorder (TUD). The most efficacious strategies being used at the VA for smoking cessation only result in a 23% abstinence rate, and veterans with PTSD only achieve a 4.5% abstinence rate. Therefore, there is a critical need to develop more effective treatments for smoking cessation. Recent studies have revealed the insula as integrally involved in the neurocircuitry of TUD, specifically showing that individuals with brain lesions involving this region had drastically improved quit rates. Some of these studies show a probability of quitting up to 5 times greater compared to non-insula lesioned regions). Altered activity of the insula may be involved in the disruption of the salience network’s (SN) connectivity to the executive control network (ECN), which compromises that patient’s ability to switch between interoceptive states focused on cravings to executive and cognitive control. Thus, we propose a feasibility phase II randomized controlled trial (RCT) to study a patterned form of repetitive transcranial magnetic stimulation (rTMS), intermittent theta burst stimulation (iTBS), at 90% of the subject’s resting motor threshold (rMT) applied over a region in the right post-central gyrus most functionally connected to the right posterior insula. We hypothesize that by increasing functional connectivity between the SN with the ECN to enhance executive control and by decreasing connectivity with the default mode network (DMN) to reduce interoceptive focus on withdrawal symptoms, we will improve smoking cessation outcomes. Fifty eligible veterans with comorbid TUD and PTSD will be randomly assigned to two conditions: active-iTBS + cognitive behavioral therapy (CBT) + nicotine replacement therapy (NRT) ( n =25) or sham-iTBS + CBT + NRT ( n =25). The primary outcome, feasibility, will be determined by achieving a recruitment of 50 participants and retention rate of 80%. The success of iTBS will be evaluated through self-reported nicotine use, cravings, withdrawal symptoms, and abstinence following quit date (confirmed by bioverification) along with evaluation for target engagement through neuroimaging changes, specifically connectivity differences between the insula and other regions of interest.
Study Design: Retrospective Cohort Study. Objectives: To evaluate clinical and patient reported outcomes between operative and non-operative management strategies for sacral U-type fractures. Methods: This retrospective review included patients with sacral U-type fractures from a 12-year period at a Level 1 trauma center. Demographic, Modified 5-Item Frailty Index (mFI-5), complications, outcomes, and Patient-Reported Outcomes Measurement Information System (PROMIS) data were collected. Fractures were classified by the AO Spine Sacral Injury Classification System (AOSSIC) and analyzed by subtype and treatment modality (trans-sacral screw fixation (TSF) or lumbopelvic fixation (LPF) vs non-operative). Statistical significance was P < .05. Results: Sixty-five patients met inclusion criteria (mean age 59.7 ± 21.3 years, 49% male). Forty-seven (72%) were treated operatively (10 LPF, 37 TSF) and 18 non-operatively. Among C0 fractures, PROMIS Pain Interference (PI) and Physical Function (PF) scores were similar between operative and non-operative groups (62.96 vs 66.08, P = .48; 30.01 vs 32.40, P = .62). Similar findings were observed for C3 fractures (PI 62.62 vs 64.23, P = .58; PF 30.29 vs 29.3, P = .78). mFI-5 frailty scores were higher among non-operative C3 fracture patients compared to operative cases (2.25 vs 0.90, P < .001). Complication rates were low and comparable between groups. Symptomatic screw removal occurred in 8% of TSF cases. Conclusions: Operative and non-operative management of AOSSIC Type C sacral fractures yield comparable PROMIS outcomes and complication rates when frailty scores are considered. TSF was associated with higher rates of symptomatic screw removal. Further investigation is needed to determine the optimal treatment and impact of frailty metrics for these injuries.
Study Design: Retrospective matched case-control study. Objectives: Pelvic fixation failure (PFF) is a rare, underrecognized mechanical complication from surgical management of adult spinal deformity (ASD). Studies show that residual postoperative malalignment may increase mechanical stress on pelvic instrumentation, but the role of global radiographic parameters in predicting PFF remains poorly defined. Our study aims to identify radiographic predictors of PFF and evaluate the time-dependent relationship between residual deformity and PFF rates. Methods: This was a single-center, retrospective, matched case-control study of ASD patients who underwent pelvic fixation from 2016-2024 and had >1-year postoperative follow-up. PFF was defined as any reoperation for pelvic screw or rod failure, and patients were matched in a 1:4 ratio by age and sex. Global radiographic outcome measures were collected, and multivariable logistic regression and Cox proportional hazard models were used to assess PFF predictors and time-to-failure. Results: 31 (5.99%) of 517 eligible patients experienced PFF, and 94 patients were included in total after propensity matching with 63 eligible controls. Postoperative C2 Tilt (C2T) (OR: 1.15, P = 0.013) and ΔC7-Central Sacral Vertical Line (ΔC7-CSVL) (OR: 1.66, P = 0.007) were associated with increased PFF risk. T1-Pelvic Angle (T1PA) trended toward significance ( P = 0.062). Time-to-event analysis confirmed these findings and identified a C2T cutoff for hazard ratio>1 of 6.9°. Conclusions: Residual postoperative global spinal imbalance, specifically C2T, is a significant predictor of PFF and accelerated time-to-failure. This highlights the importance of achieving global alignment intraoperatively to improve long-term construct durability and prevent PFF complications in ASD surgery.
Case: A 12-year-old boy with congenital scoliosis underwent posterior spinal fusion from C7 to T7 with a vertebral column resection (VCR) of T3 to T4. Postoperatively, he developed left-sided ptosis and miosis with an unremarkable MRI of the head, cervical, and thoracic spine. Apraclonidine testing confirmed Horner syndrome. The patient required no ophthalmologic intervention and demonstrated continued functional and symptom improvement at 6 months with stable spinal alignment. Conclusion: This case highlights Horner syndrome as a rare potential complication of VCRs without epidural analgesia, emphasizing the need for additional counseling to families on this potential postoperative outcome.